Home » Archive

Channels

Drug Development, News, Syndication, Xconomy »

After Raising $59M, aTyr Plans Physiocrines Proof-of-Concept Trials

Posted by sandiegobiotech July 28th, 2013 .
No Comments

San Diego’s aTyr Pharma says today it has closed on $59 million in a Series D financing to advance its development of a new class of protein-based drugs for treating rare immune diseases. The $59…

[[Click headline to continue reading.]]

More...

Diagnostics, News, Syndication, Xconomy »

MD Revolution Offers Blueprint for “Health Management” Practice

Posted by sandiegobiotech June 26th, 2013 .
No Comments

On the seventh floor of a medical office building near Scripps Memorial Hospital La Jolla, Dr. Samir Damani has established a prototype medical practice of the future. The suite looks more like a spa…

[[Click headline to continue reading.]]

More...

Drug Development, News, Syndication, Xconomy »

Constructing Innovation Supply Chains for the Pharmaceutical Industry

Posted by sandiegobiotech June 26th, 2013 .
No Comments

Competition via innovation has been recognized as essential for mid- to long-term success and even survival of science-based corporations such as pharmaceutical and biotechnology companies. As such,…

[[Click headline to continue reading.]]

More...

Diagnostics, News, Syndication, Xconomy »

The Biotech IPO Scorecard: Who’s Up, Who’s Down in 2013

Posted by sandiegobiotech June 3rd, 2013 .
No Comments

Remember Plexxikon? The Berkeley, CA-based company had a lot of talent for structural biology-based drug design, an impressive new treatment for melanoma, and a strong management team. Two years ago,…

[[Click headline to continue reading.]]

More...

Conferences, News, Syndication, Xconomy »

Zillions of Biotech Conferences Want You. Which Should You Attend?

Posted by sandiegobiotech May 20th, 2013 .
No Comments

Biotech industry conferences are happening, somewhere on this green Earth, every day. If you’ve been around a while, and you’ve attended a few, chances are you get invitations, or marketing pitches,…

[[Click headline to continue reading.]]

More...

Drug Development, News, Syndication, Xconomy »

San Diego’s Receptos, Ambit Biosciences, Get Ready for IPO Debuts

Posted by sandiegobiotech May 6th, 2013 .
No Comments

[Corrected 5/6/13, 10:50 am. See below.] San Diego-based Receptos, a biotech developing new treatments for immune disorders, is among 13 IPOs expected to go public this week, according to Renaissance…

[[Click headline to continue reading.]]

More...

Drug Development, News, Syndication, Xconomy »

Abide Therapeutics and Merck Unveil Diabetes Drug Collaboration

Posted by sandiegobiotech May 2nd, 2013 .
No Comments

Abide Therapeutics, a two-year-old San Diego biopharmaceutical firm pioneering new ways to identify and validate drug targets among the serine hydrolase “superfamily” of enzymes, says today it has…

[[Click headline to continue reading.]]

More...

Drug Discovery, News, Syndication, Xconomy »

Using Bioprinting Technology, San Diego’s Organovo Makes 3D Tissue

Posted by sandiegobiotech April 23rd, 2013 .
No Comments

Organovo, a San Diego regenerative medicine company developing bio-printing technology, says it has used its proprietary NovaGen bioprinter to produce 3D samples of human liver cells that show some…

[[Click headline to continue reading.]]

More...

Diagnostics, News, Syndication, Xconomy »

Thermo Fisher Scientific Acquires Life Technologies in $13.6B Deal

Posted by sandiegobiotech April 15th, 2013 .
No Comments

Waltham, MA-based Thermo Fisher Scientific (NYSE: TMO) said today it will pay $13.6 billion to acquire Carlsbad, CA-based Life Technologies (NASDAQ: LIFE) following an auction that began in January…

[[Click headline to continue reading.]]

More...

Drug Development, News, Syndication, Xconomy »

Rare FDA Ruling Triggers Stampede for Acadia Pharmaceuticals

Posted by sandiegobiotech April 11th, 2013 .
No Comments

How often does the FDA tell a drug developer to dispense with a requisite, second late-stage trial—and to proceed with filing a new drug application? Shares of San Diego’s Acadia…

[[Click headline to continue reading.]]

More...